Glaukos Corporation (GKOS) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Medical - Devices उद्योग. कंपनी का मुख्यालय है Aliso Viejo, CA, United States. वर्तमान CEO हैं Thomas William Burns.
GKOS के पास है IPO तिथि 2015-06-25, 995 पूर्णकालिक कर्मचारी, पर सूचीबद्ध NYSE, बाजार पूंजीकरण $7B.
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company headquartered in San Clemente, California, specializing in innovative therapies for glaucoma, corneal disorders, and retinal diseases. The company's flagship products include the iStent family of micro-bypass stents—iStent, iStent inject, and iStent inject W—which are implanted during cataract surgery to improve aqueous humor outflow and treat mild-to-moderate open-angle glaucoma. Its pipeline includes iStent Infinite, a three-stent system designed for standalone use in refractory glaucoma patients, and iDose TR, a targeted injectable implant that delivers therapeutic medication levels. Glaukos markets its products globally through a combination of direct sales operations and distributor networks. Founded in 1998, the company continues to advance minimally invasive surgical solutions for serious eye conditions.
